Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Byrne

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cancer Research|November 11, 2011
Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancerDamian McCartan, Jarlath C Bolger, Aílis Fagan, et al.
Cancer Research|January 28, 2010
FKBPL regulates estrogen receptor signaling and determines response to endocrine therapyHayley D McKeen, Christopher Byrne, Puthen V Jithesh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2012
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cellsJane O'Hara, Damir Vareslija, Jean McBryan, et al.
Endocrinology|August 2, 2008
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signalingHayley D McKeen, Kerry McAlpine, Andrea Valentine, et al.
BMJ Open|November 7, 2018
Development and prospective external validation of a tool to predict poor recovery at 9 months after acute ankle sprain in UK emergency departments: the SPRAINED prognostic modelMichael M Schlussel, David J Keene, Gary S Collins, et al.
BMC Medicine|April 13, 2017
S100β as a serum marker in endocrine resistant breast cancerSara Charmsaz, Éamon Hughes, Fiona T Bane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine TherapyJean McBryan, Ailís Fagan, Damian McCartan, et al.
Cancer Research|March 21, 2014
Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesisClaire A Walsh, Jarlath C Bolger, Christopher Byrne, et al.
BMJ Open Diabetes Research & Care|March 7, 2020
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levelsKenneth I Zheng, Wen-Yue Liu, Xiao-Yan Pan, et al.
Health Technology Assessment (Winchester, England)|November 27, 2018
Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation studyDavid J Keene, Michael M Schlüssel, Jacqueline Thompson, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cancer Research|November 11, 2011
Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancerDamian McCartan, Jarlath C Bolger, Aílis Fagan, et al.
Cancer Research|January 28, 2010
FKBPL regulates estrogen receptor signaling and determines response to endocrine therapyHayley D McKeen, Christopher Byrne, Puthen V Jithesh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2012
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cellsJane O'Hara, Damir Vareslija, Jean McBryan, et al.
Endocrinology|August 2, 2008
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signalingHayley D McKeen, Kerry McAlpine, Andrea Valentine, et al.
BMJ Open|November 7, 2018
Development and prospective external validation of a tool to predict poor recovery at 9 months after acute ankle sprain in UK emergency departments: the SPRAINED prognostic modelMichael M Schlussel, David J Keene, Gary S Collins, et al.
BMC Medicine|April 13, 2017
S100β as a serum marker in endocrine resistant breast cancerSara Charmsaz, Éamon Hughes, Fiona T Bane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine TherapyJean McBryan, Ailís Fagan, Damian McCartan, et al.
Cancer Research|March 21, 2014
Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesisClaire A Walsh, Jarlath C Bolger, Christopher Byrne, et al.
BMJ Open Diabetes Research & Care|March 7, 2020
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levelsKenneth I Zheng, Wen-Yue Liu, Xiao-Yan Pan, et al.
Health Technology Assessment (Winchester, England)|November 27, 2018
Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation studyDavid J Keene, Michael M Schlüssel, Jacqueline Thompson, et al.
Pageof 8